Keyphrases
Parkinson's Disease
45%
Meta-analysis
33%
Delusions
25%
Hallucinations
25%
Acetylcholinesterase Inhibitors (AChEI)
22%
Alzheimer's Disease
22%
Systematic Meta-analysis
19%
Stimulating Agent
16%
Cholinergic Degeneration
16%
Depressive Disorder
16%
Dopamine
16%
Psychotic Symptoms
16%
Idiopathic Parkinson's Disease
16%
GBA mutations
16%
FEOBV
16%
Cholinergic Innervation
16%
Parkinson Patients
16%
Parkinsonian
16%
Acetylcholine
16%
Psychosis
16%
PET Scan
11%
Cognitive Domains
9%
Neuropsychiatric
8%
Dementia with Lewy Bodies
8%
GBA1
8%
PET Imaging
8%
Clinical Features
8%
Volume-of-interest
8%
Cholinergic System
8%
Depressive Symptoms
6%
Aging Effect
6%
Publication Bias
6%
Monotherapy
6%
Data Extraction
5%
Neuropsychiatric Symptoms
5%
Individual Participant Data
5%
Randomized Clinical Trial
5%
Parkinson's Disease Dementia
5%
Inhibitor Treatment
5%
Beneficial Effects
5%
Functional Magnetic Resonance Imaging
5%
Brain Disorders
5%
Magnetic Stimulation
5%
Non-motor Symptoms
5%
Neurotransmitters
5%
Short-latency Afferent Inhibition
5%
Statistical Methods
5%
Tremor
5%
Brain Patterns
5%
Typical Symptoms
5%
Neuroscience
Parkinson's Disease
100%
Cholinergic
66%
Positron Emission Tomography
38%
Meta-Analysis
33%
Fluorine-18
27%
Delusion
25%
Hallucination
25%
Cognitive Disorders
22%
Denervation
22%
Alzheimer's Disease
22%
Acetylcholinesterase Inhibitor
22%
Visual Hallucination
22%
Ictal
16%
Electroencephalography
16%
Depression
16%
Analeptic
16%
Parasympathetic Innervation
16%
Acetylcholine
16%
Dopaminergic
10%
Positron Emission Tomography
10%
Neurotransmitter
8%
Dementia with Lewy Bodies
8%
Magnetic Resonance Imaging
5%
Brain Disease
5%
Tremor
5%
Non-Motor Symptoms
5%
Functional Magnetic Resonance Imaging
5%
